Background: The risk of the acute respiratory distress syndrome (ARDS) is increased in passive and active smokers after blunt trauma. However, the mechanisms responsible, including the role of platelet aggregation, for this association are unknown. Methods: We analyzed 215 patients with severe blunt trauma from a prospective observational cohort at a Level 1 trauma center between 2010 - 2015. Subjects underwent impedance-based platelet aggregometry in response to platelet agonists arachidonic acid (ASPI), adenosine diphosphate (ADP), collagen (COL) and thrombin receptor activating peptide-6 (TRAP). ARDS within the first 8 days of admission was adjudicated using Berlin criteria. Plasma cotinine was measured to assess cigarette smoke exposure. Regression analyses were used to assess the relationship between 1) platelet aggregation and ARDS and 2) cigarette smoke exposure and platelet aggregation. Results: At both 0 and 24 hours, impaired platelet aggregation was associated with increased odds of developing ARDS. Cigarette smoke exposure was associated with increased platelet aggregation upon arrival to the emergency department. However, at 24 hours, cigarette smoke exposure was associated with increased impairment in platelet aggregation, reflecting a statistically significant decline in platelet aggregation over the initial 24 hours following trauma. The relationship between this decline in platelet aggregation and ARDS differed by cigarette smoke exposure status, suggesting that impaired platelet activation differentially affects the risk of ARDS in those with cigarette smoke exposure (ASPI, p for interaction: 0.005, COL p for interaction: 0.02, ADP, p for interaction: 0.05). Conclusions: Impaired platelet aggregation at 0 and 24 hours is associated with an increased risk of developing ARDS after severe blunt trauma. Cigarette smoke exposed patients are more likely to develop impaired platelet aggregation over the first 24 hours of admission, which may contribute to their increased risk of ARDS. Level of Evidence: Prognostic/Epidemiological, Level III (C) 2017 Lippincott Williams & Wilkins, Inc.
from Emergency Medicine via xlomafota13 on Inoreader http://ift.tt/2APjBdM
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Neurosurgical contribution within a complex NF1 supraregional service Publication date: May 2019 Source: Clinical Neurology and Neurosurger...
-
Abstract Purpose To identify predictive factors for local control of locally advanced esophageal cancer by chemoradiotherapy, the relati...
-
Abstract In addition to its critical role in lysosomes for catabolism of sialoglycoconjugates, NEU1 is expressed at the plasma membrane an...
-
Abstract Neurodegenerative diseases (NDs) are a group of chronic, progressive disorders characterized by the gradual loss of neurons that ...
-
Abstract Rheumatoid arthritis (RA) and psoriatic arthritis (PsA) are common in women of childbearing age and are often treated with terato...
-
Abstract The last 15 years have overwhelmed the surgical community with a range of approaches in treating pathologies involving the aortic...
-
Abstract Background Gliomas with 1p/19q-codeletion as well as mutation of isocitrate dehydrogenase ( IDH ) 1 are typically characteriz...
-
Abstract Background Adenoid cystic carcinoma (ACC) is a salivary gland malignancy with poor long-term survival, which warrants studies a...
-
Abstract Background We evaluated our results of lengthening of free vascularized fibular grafts using a unilateral external fixator in p...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου